New Guidance from the American College of Obstetricians and Gynecologists for Fibroid Management Supports Incisionless Transcervical Radiofrequency Ablation as a Uterus-Preserving Treatment Option Additionally, an expert physician panel in Europe reached consensus and published a new recommended fibroid treatment algorithm with transcervical radiofrequency ablation (Sonata) at the forefront [...]
Gynesonics announces positive payer coverage issued by Health Care Service Corporation (HCSC) for the Sonata Treatment HCSC is the largest customer-owned health insurer in the United States, operating Blue Cross and Blue Shield® Plans in Illinois, Montana, New Mexico, Oklahoma, and Texas Redwood City, CA, March 15, 2021 – [...]
Sonata Treatment provides patients with an incision-free, outpatient option with exceptional results and fast recovery Redwood City, Calif. – September 3, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Brigham and Women’s Faulkner Hospital is [...]
Clinical Study Demonstrates No Adhesion Formation at Second-Look Hysteroscopy Performed Six Weeks After Transcervical Fibroid Ablation with the Sonata System Redwood City, Calif. – August 20, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of [...]
Positive aspects of transcervical fibroid ablation, strong clinical results, provides facilities with confidence in treating fibroids and minimizing potential viral risks – procedural volumes increasing Redwood City, CA – June 22, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, [...]
MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced European Spine Journal publication of long-term data from the Level I SMART trial showing durability of improvements in pain and function beyond 5 years [...]
The Sonata System provides advantages in reducing the index procedure cost, length of stay (LOS), prescription medications, complications and radiology costs versus hysterectomy and myomectomy Redwood City, CA – June 4, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine [...]
Early launch in Europe contributes to significant procedural growth Redwood City, CA – May 28, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) [...]
SOPHiA GENETICS Expands its Executive Team, Naming Lara Hashimoto Chief Business Officer Lausanne, Switzerland, and Boston, United States, April 8, 2020 - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be [...]
Free Virtual Training Offered to Meet Growing Demand from Most Vulnerable Healthcare Segment for Increased Education and Support QUINCY, MA – March 17, 2020 – In response to the global COVID-19 pandemic, IntelyCare, a leading intelligent workforce management solution for post-acute facilities, is launching the first training certification program [...]